Belgian Medical Equipment Stock News

Goldman Sachs has disclosed a new holding in Umicore (ENXTBR:UMI), crossing the 3% voting rights threshold. The stake was reported in a recent regulatory filing, confirming Goldman Sachs as a significant shareholder in the company. Umicore operates in materials technology and recycling, supplying key components for sectors such as batteries, automotive catalysts and specialty materials. The company is involved in long term themes related to electrification, resource efficiency and circular...

Amidst a backdrop of easing inflation and stable unemployment rates, European markets have shown resilience with the STOXX Europe 600 Index rising by nearly 2% over recent days. This positive sentiment is further buoyed by lower oil prices, which may mitigate economic concerns stemming from Middle Eastern conflicts. In such an environment, identifying undervalued stocks can be particularly advantageous as they might offer potential growth opportunities when market conditions stabilize further.

Colruyt Group (ENXTBR:COLR) is back on investors’ radars after a recent upgrade to a Zacks Rank #1 Strong Buy, driven by analysts raising earnings estimates and signalling greater confidence in the company’s fundamentals. See our latest analysis for Colruyt Group. The upbeat earnings outlook for Colruyt Group has arrived alongside building momentum in the share price, with a 30 day share price return of 9.6% and a year to date share price return of 15.82%. At the same time, the 3 year total...

Why argenx Stock Is Drawing Fresh Attention argenx (ENXTBR:ARGX) is back in focus after recent technical coverage highlighted a breakout to an all time high and recognition as a top growth stock related to its myasthenia gravis treatment. This attention arrives alongside current figures such as a €812.20 last close, approximately 21% return over the past 3 months, and a reported €4,742.469 revenue base from its biotechnology operations. See our latest analysis for argenx. Against this...

Anheuser-Busch InBev (ENXTBR:ABI) is drawing investor attention as revenue growth and margin performance are tied to its premium brands Corona, Stella Artois, and Michelob Ultra, alongside expanding digital platforms such as BEES and Zé Delivery. See our latest analysis for Anheuser-Busch InBev. At a share price of €72.44, Anheuser-Busch InBev has a 30 day share price return of 7.0% and a 90 day share price return of 17.56%. The 3 year total shareholder return of 47.93% points to momentum...

Cmb.Tech (ENXTBR:CMBT) drew fresh attention after agreeing with Fortescue to charter up to 12 ammonia capable Newcastlemax vessels, highlighting the company’s role in emerging low carbon shipping solutions. See our latest analysis for Cmb.Tech. The Fortescue charter news comes after a strong run in Cmb.Tech’s stock, with the share price at €13.22 and a year to date share price return of 64.02%, while the 1 year total shareholder return of 72.33% signals solid momentum on top of longer term...

Pixelworks, Inc. recently announced a partnership with Kinepolis Group to bring TrueCut Motion-enhanced versions of new theatrical releases to Kinepolis’ Laser Ultra premium large-format screens, aiming to deliver clearer, more immersive motion while preserving filmmakers’ intent. This collaboration highlights how Kinepolis is leaning on advanced motion-grading technology to differentiate its premium cinema offering and deepen the appeal of its high-end screens for moviegoers and content...

DEME Group (ENXTBR:DEME) has drawn fresh investor attention after committing to build a 22,000 m³ trailing suction hopper dredger, a sizeable fleet upgrade focused on productivity, cost efficiency, and lower greenhouse gas intensity. See our latest analysis for DEME Group. At a share price of €173.6, DEME Group has seen a 1-day share price return of 1.28%, while the 30-day and 90-day share price returns are down 5.03% and 8.63% respectively. However, the year to date share price return of...

Pixelworks has announced a partnership with Kinepolis Group (ENXTBR:KIN) to roll out TrueCut Motion versions of new theatrical releases across Kinepolis’ Laser Ultra screens, sharpening the focus on premium cinema presentation for audiences. See our latest analysis for Kinepolis Group. The €36.5 share price sits against a strong recent run, with a 30-day share price return of 21.46% and a 90-day share price return of 37.22%. However, the 5-year total shareholder return is down 20.56%,...

In late June 2026, Wells Fargo named argenx a top Q3 tactical pick, highlighting an upcoming clinical catalyst as a key focus for investors. This endorsement brings fresh attention to how argenx’s pipeline progress and near-term milestones could influence expectations for its autoimmune portfolio. We’ll now examine how Wells Fargo’s Q3 tactical pick call and the looming clinical catalyst feed into argenx’s existing investment narrative. The future of work is here. Discover the 29 top...

As European markets continue to navigate mixed macroeconomic data and geopolitical developments, the pan-European STOXX Europe 600 Index has shown resilience with a modest gain. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best.

Readers hoping to buy Azelis Group NV ( EBR:AZE ) for its dividend will need to make their move shortly, as the stock...

UCB (ENXTBR:UCB) stock is in focus after new Brain Communications data on KYGEVVI for early onset TK2 deficiency highlighted improved survival and functional outcomes, along with acceptable tolerability in treated patients. See our latest analysis for UCB. The latest KYGEVVI data arrives as UCB shares trade at €255.0, with an 8.88% year to date share price return and a 51.64% total shareholder return over 1 year. This points to strong long term momentum alongside more modest recent gains. If...

CMB.TECH NV announced that it has signed a milestone agreement with Fortescue for the charter of up to 12 ammonia-capable Newcastlemax vessels, including up to three dual-fuel ammonia ships expected to enter service by the end of 2026. The deal highlights CMB.TECH’s growing role in advancing ammonia as a marine fuel, with the potential to materially cut shipping emissions if powered by green ammonia. Next, we’ll examine how this large-scale ammonia-capable charter agreement with Fortescue...

Cenergy Holdings SA ( EBR:CENER ), is not the largest company out there, but it received a lot of attention from a...

The resignation of Frederik Vandepitte as CEO of Cera Group and KBC Ancora, key anchor shareholders controlling over 41% of KBC Group (ENXTBR:KBC), puts governance and long term shareholder influence in sharper focus for investors. See our latest analysis for KBC Group. KBC Group’s recent share price return paints a mixed picture, with the stock down 0.7% on the day to €119.05 but recording a 7.4% 7 day and 9.4% 30 day share price return, alongside a 1 year total shareholder return of 46.3%...

The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...

European markets have shown mixed performance recently, as investors navigate the European Central Bank's interest rate hikes and ongoing geopolitical tensions. Despite these challenges, there remains a keen interest in exploring investment opportunities within smaller or newer companies that may offer significant growth potential. While the term "penny stocks" may seem outdated, it continues to capture the essence of investing in companies with lower market capitalizations that could present...

Earlier in June 2026, ELIQUENT Life Sciences announced that UCB went live with the full Veeva Safety Suite, consolidating its global pharmacovigilance operations into a single cloud-based platform delivered in collaboration with Veeva, Pinnaxis, and Daelight Solutions. Separately, UCB and Biogen presented Phase 3 PHOENYCS GO data at EULAR 2026 suggesting dapirolizumab pegol may help systemic lupus erythematosus patients sustain disease control while reducing long-term steroid exposure,...

Dividend announcement and what it means for investors D'Ieteren Group (ENXTBR:DIE) has declared an annual dividend of €1.40 per share, with an ex dividend date on 9 June 2026, record date on 10 June and payment on 11 June. This dividend decision puts income directly on the table for shareholders. It also offers a fresh data point on how management is choosing to return cash alongside the group’s investment focused business model. See our latest analysis for D'Ieteren Group. The dividend news...

Proximus (ENXTBR:PROX) and Unifiber SA recently held an M&A call indicating interest in a potential transaction. The discussion signals that both companies are assessing options for closer collaboration or corporate action. Details on structure, timing, and financial terms have not been made public. For investors watching Proximus at a share price of €6.61, the prospect of an M&A move with Unifiber SA comes after a mixed share price record. The stock is down 7.6% year to date and down 44.3%...

Recent performance snapshot for Ackermans & Van Haaren (ENXTBR:ACKB) Ackermans & Van Haaren (ENXTBR:ACKB) has drawn attention after a period where the stock is up 12.7% year to date, yet down 6.5% over the past month and 4.9% over the past 3 months. At a last close of €262.20 and a market value of about €8.57b, the company reports annual revenue of €5,961.61m and net income of €592.55m, with annual revenue growth of 2.18% and net income growth of 5.72%. See our latest analysis for Ackermans &...

Tessenderlo Group NV ( EBR:TESB ) stock is about to trade ex-dividend in three days. The ex-dividend date is two...

ageas SA/NV ( EBR:AGS ) is about to trade ex-dividend in the next four days. The ex-dividend date is two business days...